Clinical Trial Detail

NCT ID NCT04172844
Title Pevonedistat, Azacitidine, and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia (PAVE)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ehab L Atallah
Indications

acute myeloid leukemia

Therapies

Azacitidine + MLN4924 + Venetoclax

Age Groups: senior adult

No variant requirements are available.